The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.
Masimo devices with SpHb, SpCO, and/or SpMet monitoring are not intended to replace laboratory blood testing. Blood samples should be analysed by laboratory instruments prior to clinical decision making.
Duplicate abstracts or publications are excluded
This section is intended to provide access to clinical studies conducted using Masimo noninvasive technologies, parameters, and products. We cannot guarantee that all published clinical studies, abstracts and research are listed here. To view individual clinical studies please click on the appropriate tab.
Some uses of the manufacturer’s devices described in the information may not have been approved or cleared by the FDA. See manufacturer labeling for the indications in the product’s cleared indications for use statement.
Clinical evidence is provided to illustrate the performance and accuracy of Masimo technologies. Federal law restricts Masimo devices for medical uses to sale by or on the order of a physician.